FeesSafety
Pluang+

UBS Group AG's stake in Bang & Olufsen drops below 5% after previously exceeding it.

05 Nov 2026, 14:00 WIB
Na
View Source
Neutral
UBS Group AG's stake in Bang & Olufsen drops below 5% after previously exceeding it.

UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This change reflects UBS adjusting its position in the company, which is relevant for investors tracking major shareholders. No further details on UBS's intentions were provided.

UBS Group AG's shareholding update in Bang & Olufsen A/S is noted here with Pluang's Consumer Cyclical sector market data as of Nov 05, 2026 14:11 WIB. For readers following Consumer Cyclical stocks, out of 134 priced US stocks on Pluang, 85 advanced and 41 declined today. Notable movers include DHI at USD 158.00 with a +8.79% change, ANF at USD 171.25 up +8.72%, and UA at USD 5.56 gaining +8.17%.

More News

T-Therapeutics raises $133M to advance novel TCR bispecific therapies for cancer and autoimmune diseases

T-Therapeutics raises $133M to advance novel TCR bispecific therapies for cancer and autoimmune diseases

T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...

Company Fundamentals
Bullish
54 minutes ago
Siemens Healthineers spins off diagnostics unit as Olyrian Diagnostics, aiming for standalone status by 2028

Siemens Healthineers spins off diagnostics unit as Olyrian Diagnostics, aiming for standalone status by 2028

Siemens Healthineers has begun separating its in vitro diagnostics business into a standalone company named Olyrian Diagnostics, expected to complete by mid-2028. This move aims to give the diagnostics unit a distinct market presence while continuing...

Company Fundamentals
Bullish
1 hour ago
IQM Quantum Computers' order backlog grows 52% in 2026 Q3; reaffirms full-year guidance.

IQM Quantum Computers' order backlog grows 52% in 2026 Q3; reaffirms full-year guidance.

IQM Quantum Computers reported a 52% increase in order backlog to €102.5 million by September 30, 2026, driven by major new contracts including the LUMI-IQ Halocene order. Q3 revenue rose 51% year-over-year to €8.9 million, with cash reserves at €260...

Company Fundamentals
Bullish
1 hour ago
IQM Quantum Computers boosts order backlog 52% in 2026, reaffirms full-year revenue guidance.

IQM Quantum Computers boosts order backlog 52% in 2026, reaffirms full-year revenue guidance.

IQM Quantum Computers reported a 52% increase in order backlog to EUR 102.5 million by September 2026, driven by strong new orders including a EUR 33 million contract for its error-correction platform. Q3 revenue rose 51% year-over-year to EUR 8.9 mi...

Company Fundamentals
Bullish
1 hour ago
Financial firms rapidly adopt multi-agent AI but few achieve full enterprise orchestration yet.

Financial firms rapidly adopt multi-agent AI but few achieve full enterprise orchestration yet.

Financial institutions are increasingly deploying multi-agent AI systems to enhance banking and insurance workflows, with 59% piloting or deploying such systems. However, only 10% have achieved full enterprise-wide orchestration, highlighting challen...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App